FDA Proposal For Cybersecurity Info In Pre-market Submissions Generates Debate
This article was originally published in The Gray Sheet
Executive Summary
Medical device firms and internet security groups disagree over whether an FDA guidance should recommend that companies document their cybersecurity measures in pre-market submissions.